GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. by Ziyue Liu (381532)

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. by Lei Li (29537)

Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

S1 Data. Bibliometric analysis. S2 Data. Estrogen level analysis. S3 Data. MicroCT quantification. S4 Data. Markers of bone metabolism. by Yan She (8639796)

Disruption of putative host factor LGMN decreases SARS-CoV-2 viral entry. by Ravi K. Dinesh (21736629)

Assessment of conditions associated with decrease in systemic vascular resistance one month prior to NAION onset and in matched controls. by Jasmin Gabbay (20323916)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Superimposed structures of deleterious variants C321R(5a), I151N(5b), K142M(5c), L189P(5d), M179R(5e), and S184L(5f). by Wei Fan (109074)

Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…In the non-recurrence group, the respective preoperative treatment counts were 2.6 ± 1.1, 0.5 ± 0.9, 0.6 ± 0.9, 0.1 ± 0.3, and 3.8 ± 1.3, and no additional treatments were required during the 3 postoperative years. …”

Developmental status of non-eclosing <i>Cotesia ruficrus.</i> by Xian Li (201841)

LncRNA <i>C5orf64</i> polymorphisms (rs12518552 and rs2950218) decreases pulmonary tuberculosis susceptibility by Shilin Xu (1884217)

Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

Cell cycle-specific expression of Clb1 and Clb2 protein was also decreased in the <i>puf5</i>Δ mutant. by Megumi Sato (4116994)

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”